NASDAQ:HYPR Hyperfine (HYPR) Stock Price, News & Analysis $1.16 +0.01 (+0.87%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.15▼$1.1850-Day Range$0.80▼$1.2452-Week Range$0.76▼$3.15Volume62,526 shsAverage Volume96,929 shsMarket Capitalization$83.46 millionP/E RatioN/ADividend YieldN/APrice Target$2.12 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Hyperfine alerts: Email Address Hyperfine MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside82.5% Upside$2.12 Price TargetShort InterestBearish3.08% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.22Based on 2 Articles This WeekInsider TradingSelling Shares$2,423 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.53) to ($0.52) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 starsMedical Sector740th out of 936 stocksElectromedical Equipment Industry19th out of 22 stocks 3.2 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageHyperfine has received no research coverage in the past 90 days.Read more about Hyperfine's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted3.08% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.Change versus previous monthShort interest in Hyperfine has recently increased by 7.35%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 1.8 News and Social Media Coverage News SentimentHyperfine has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for HYPR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,423.00 in company stock.Percentage Held by Insiders29.42% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.03% of the stock of Hyperfine is held by institutions.Read more about Hyperfine's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Hyperfine are expected to grow in the coming year, from ($0.53) to ($0.52) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -1.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -1.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Hyperfine's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview About Hyperfine Stock (NASDAQ:HYPR)Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Read More HYPR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HYPR Stock News HeadlinesJuly 19, 2024 | americanbankingnews.comShort Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 6.3%May 28, 2024 | businesswire.comHyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to IndiaJuly 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."May 24, 2024 | investorplace.comThe Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare ChangeMay 22, 2024 | businesswire.comHyperfine, Inc. to Present at the Jefferies Global Healthcare ConferenceMay 22, 2024 | finance.yahoo.comHyperfine, Inc. Celebrates ASNR 2024May 14, 2024 | msn.comHyperfine, Inc. (NASDAQ:HYPR) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comHyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and ChallengesJuly 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."May 13, 2024 | investorplace.comHYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024May 13, 2024 | globenewswire.comHyperfine, Inc. Reports First Quarter 2024 Financial ResultsMay 10, 2024 | businesswire.comHyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European MarketsApril 23, 2024 | businesswire.comHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsApril 17, 2024 | msn.comHyperfine (HYPR) Price Target Decreased by 6.02% to 1.33April 17, 2024 | businesswire.comLeading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyMarch 23, 2024 | markets.businessinsider.comChallenges Ahead: Revising Hyperfine’s Outlook Amid Lower-than-Expected Financial PerformanceMarch 22, 2024 | msn.comHyperfine, Inc. (NASDAQ:HYPR) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | investorplace.comHYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023See More Headlines Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees131Year FoundedN/APrice Target and Rating Average Stock Price Target$2.12 High Stock Price Target$3.50 Low Stock Price Target$1.25 Potential Upside/Downside+82.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,240,000.00 Net Margins-358.59% Pretax Margin-358.59% Return on Equity-46.96% Return on Assets-42.42% Debt Debt-to-Equity RatioN/A Current Ratio9.09 Quick Ratio8.26 Sales & Book Value Annual Sales$11.03 million Price / Sales7.57 Cash FlowN/A Price / Cash FlowN/A Book Value$1.17 per share Price / Book0.99Miscellaneous Outstanding Shares71,950,000Free Float50,782,000Market Cap$83.46 million OptionableOptionable Beta0.84 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. R. Scott Huennekens CPA (Age 60)M.B.A., Executive Chairman Comp: $1.29MMs. Maria Sainz (Age 58)CEO, President & Director Comp: $340.24kDr. Jonathan M. Rothberg Ph.D. (Age 60)Founder & Vice Chairman Comp: $51.37kMr. Brett Hale (Age 50)Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Dr. Thomas Teisseyre Ph.D.Chief Operating OfficerMr. Chip Truwit FACRM.D., Vice President of Scientific AffairsMore ExecutivesKey CompetitorsZynexNASDAQ:ZYXISemler ScientificNASDAQ:SMLROutset MedicalNASDAQ:OMEdap TmsNASDAQ:EDAPElectromedNYSE:ELMDView All CompetitorsInsidersThomas TeisseyreSold 2,753 sharesTotal: $2,422.64 ($0.88/share)Thomas TeisseyreSold 2,655 sharesTotal: $3,345.30 ($1.26/share)View All Insider Transactions HYPR Stock Analysis - Frequently Asked Questions How have HYPR shares performed this year? Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR shares have increased by 3.6% and is now trading at $1.16. View the best growth stocks for 2024 here. How were Hyperfine's earnings last quarter? Hyperfine, Inc. (NASDAQ:HYPR) issued its quarterly earnings results on Monday, May, 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). The business had revenue of $3.30 million for the quarter, compared to the consensus estimate of $3.03 million. Hyperfine had a negative net margin of 358.59% and a negative trailing twelve-month return on equity of 46.96%. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HYPR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
